This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Pre-Assessment
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
Hang on a second…

This CME Activity has expired and is no longer available for credit.

Patient-Centered Approaches to the Management of COPD

Patient-Centered Approaches to the Management of COPD



Time to Complete

1 hour


February 1, 2018


February 1, 2019
Add to Queue

Maximum Credits

1.00 / AMA PRA Category 1 CreditTM

Accredited Provider

Provided by Integrity Continuing Education, Inc.

Commercial Supporter

Supported by an educational grant from Sunovion Pharmaceuticals, Inc.

Program Description

Adults with chronic obstructive pulmonary disease (COPD) are more likely to be unable to work and have diminished activities of daily living. They also have increased comorbid conditions, difficulty walking or climbing stairs, or need special equipment to manage health problems compared with adults without COPD. Moreover, COPD is the 3rd most common cause of death in the US just behind cancer and heart disease. Despite significant local and national efforts to reduce the burden of COPD, recent data from the Nationwide Inpatient Sample (NIS) and Nationwide Emergency Department Sample (NEDS) has revealed that total hospitalizations and ED visits for COPD over the past decade have continued to increase. However, COPD is listed as one of the conditions in which hospitalizations are preventable to some degree. For patients with COPD, arthritis, depression, congestive heart failure, diabetes, coronary heart disease, and asthma are more common among patients with COPD than those without COPD.

Intended Audience

This educational initiative has been designed for pulmonologists and internal medicine physicians involved in the care of patients with COPD.

Educational Objectives

Upon completion of this educational activity, participants should be able to:

  • Describe a long-term management plan that improves disease monitoring, risk assessment, and exacerbation prevention in patients with COPD
  • Review the efficacy and safety of newer bronchodilator therapies and their combinations for patients with COPD
  • Select COPD medications and their devices based on the individualized needs of patients with COPD

Conflict Of Interest Disclosure Policy

Integrity Continuing Education, Inc. requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Integrity Continuing Education, Inc. for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Integrity Continuing Education, Inc. is committed to providing learners with high-quality CME/CE activities and related materials that promote improvement or quality in healthcare and not a specific proprietary business interest or a commercial interest.

The faculty/planners reported their financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity under the Faculty heading below.


Sleep Medicine and Lung Health Consultants
Senior Staff Physician
Pittsburgh Critical Care Associates
Pittsburgh, PA

Dr. Carlin discloses the following:
Consulting Fees and Speakers’ Bureau: AstraZeneca, GlaxoSmithKline, Monaghan Medical, Nonin, Philips Respironics, Sunovion Pharmaceuticals, Inc.

Sidney S. Braman, MD, FACP, FCCP
Professor of Medicine
Pulmonary, Critical Care, and Sleep Medicine
Icahn School of Medicine
New York, NY

Dr. Braman discloses the following:
Consultant: AstraZeneca, Covidien, Sunovion Pharmaceuticals, Inc.
Speakers’ Bureau: Genentech

Accredited Provider Disclosure

The following planner and manager, Patima Tanapat, PhD, hereby states that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.




AMA PRA Category 1 Credit(s)TM

Accreditation Statement

Integrity Continuing Education, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education (CME) for physicians.

Designation Statement

Integrity Continuing Education, Inc., designates this enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)TM .  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration. Integrity Continuing Education, Inc., and Sunovion Pharmaceuticals, Inc., do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Integrity Continuing Education, Inc., and Sunovion Pharmaceuticals, Inc. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


The information provided at this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient's medical condition.


There are no fees for participating and receiving CME credit for this activity. During the period of February 1, 2018 through February 1, 2019, participants must:

  • Read the learning objectives and faculty disclosures
  • Complete the pre-test
  • Study the educational activity
  • Complete the post-test and the evaluation form
A statement of credit will be issued only upon receipt of a completed activity evaluation form and a completed post-test with a score of 70% or higher.

For information about ACCME accreditation of this activity, please contact Integrity Continuing Education, Inc., at (855) 835-4004 or

If you have any questions relating to your certificate or other issues with this activity, please contact

Privacy Policy


Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue